Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.120
+0.020 (0.95%)
Sep 8, 2026, 4:00 PM EDT - Market closed
Grace Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 13.76 | 16.98 | 22.13 | 23.01 | 27.88 | 30.34 |
Short-Term Investments | - | - | - | - | 0.02 | 13.32 |
Cash & Short-Term Investments | 13.76 | 16.98 | 22.13 | 23.01 | 27.89 | 43.66 |
Cash Growth | -31.24% | -23.30% | -3.79% | -17.52% | -36.12% | -28.11% |
Other Receivables | 0.02 | 0.02 | 0.13 | 0.72 | 0.8 | 0.55 |
Receivables | 0.02 | 0.02 | 0.13 | 0.72 | 0.8 | 0.55 |
Prepaid Expenses | 0.56 | 0.38 | 0.45 | 0.28 | 0.6 | 0.72 |
Other Current Assets | - | - | - | - | - | 0.35 |
Total Current Assets | 14.33 | 17.38 | 22.71 | 24.01 | 29.29 | 45.28 |
Property, Plant & Equipment | 0.01 | 0 | 0 | 0.01 | 0.57 | 0.57 |
Goodwill | 8.14 | 8.14 | 8.14 | 8.14 | 8.14 | 12.96 |
Other Intangible Assets | 27.6 | 41.14 | 41.14 | 41.15 | 41.13 | 69.81 |
Total Assets | 50.07 | 66.65 | 71.99 | 73.3 | 79.12 | 128.62 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 0.41 | 0.7 | 0.6 | 1.01 | 1.24 | 1.68 |
Accrued Expenses | 0.84 | 1.44 | 1.33 | 0.68 | 2.09 | 1.48 |
Current Portion of Leases | - | - | - | - | 0.08 | 0.1 |
Total Current Liabilities | 1.25 | 2.15 | 1.93 | 1.68 | 3.41 | 3.26 |
Long-Term Leases | - | - | - | - | 0.41 | 0.19 |
Long-Term Deferred Tax Liabilities | 0.61 | 0.61 | 2.31 | 5.51 | 7.35 | 16.89 |
Other Long-Term Liabilities | - | - | 1.14 | 4.36 | - | 0.01 |
Total Liabilities | 1.86 | 2.76 | 5.38 | 11.56 | 11.17 | 20.35 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 0 | 0 | 0 | 0 | 258.29 | 257.99 |
Additional Paid-In Capital | 298.52 | 298.41 | 293.33 | 278.9 | 13.97 | 12.15 |
Retained Earnings | -244.27 | -228.48 | -220.69 | -211.12 | -198.27 | -155.84 |
Comprehensive Income & Other | -6.04 | -6.04 | -6.04 | -6.04 | -6.04 | -6.04 |
Shareholders' Equity | 48.21 | 63.9 | 66.61 | 61.74 | 67.96 | 108.27 |
Total Liabilities & Equity | 50.07 | 66.65 | 71.99 | 73.3 | 79.12 | 128.62 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | - | - | - | - | 0.49 | 0.3 |
Net Cash (Debt) | 13.76 | 16.98 | 22.13 | 23.01 | 27.41 | 43.37 |
Net Cash Growth | -31.24% | -23.30% | -3.79% | -16.05% | -36.80% | -28.49% |
Net Cash Per Share | 0.82 | 1.03 | 1.83 | 2.41 | 3.69 | 7.06 |
Filing Date Shares Outstanding | 21.04 | 16.27 | 13.83 | 9.4 | 7.44 | 7.38 |
Total Common Shares Outstanding | 16.27 | 16.02 | 13.72 | 9.4 | 7.44 | 7.38 |
Working Capital | 13.08 | 15.23 | 20.78 | 22.33 | 25.88 | 42.02 |
Book Value Per Share | 2.96 | 3.99 | 4.86 | 6.57 | 9.14 | 14.67 |
Tangible Book Value | 12.48 | 14.62 | 17.33 | 12.46 | 18.69 | 25.5 |
Tangible Book Value Per Share | 0.77 | 0.91 | 1.26 | 1.33 | 2.51 | 3.45 |
Machinery | - | 0 | 0.01 | 0.61 | 0.67 | 0.7 |